Kiniksa Pharmaceuticals International, Plc
KNSA
Revenue
112.21M
▲3.58M▲3.30%
3 Months ChangeAssets
555.30M
▲12.87M▲2.37%
3 Months ChangeLiabilities
118.29M
▲10.96M▲10.21%
3 Months ChangeFree Cash Flow
3.90M
▲8.19M▲190.96%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 10-Q
ID: 0001558370-24-013840
2024-10-29
Form 8-K
ID: 0001104659-24-112034
2024-10-07
Form 8-K
ID: 0001104659-24-106690
2024-07-25
Form 10-Q
ID: 0001558370-24-010181
2024-07-23
Form 8-K
ID: 0001104659-24-081717
2024-06-25
Form 8-K
ID: 0001104659-24-074763
2024-06-14
Form 8-K
ID: 0001104659-24-071787
2024-06-05
Form 8-K
ID: 0001104659-24-068694
2024-04-25
Form 10-Q
ID: 0001558370-24-005774
2024-04-23
Form 8-K
ID: 0001104659-24-050335